300158 logo

Shanxi Zhendong PharmaceuticalLtd XSEC:300158 Stock Report

Last Price

CN¥4.43

Market Cap

CN¥4.5b

7D

-7.1%

1Y

-32.8%

Updated

26 Dec, 2024

Data

Company Financials

Shanxi Zhendong Pharmaceutical Co.,Ltd

XSEC:300158 Stock Report

Market Cap: CN¥4.5b

300158 Stock Overview

Engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. More details

300158 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Risk Analysis

Earnings have declined by 5.3% per year over past 5 years


My Notes

Capture your thoughts, links and company narrative

Shanxi Zhendong Pharmaceutical Co.,Ltd Competitors

Shanghai Hile Bio-Technology

SHSE:603718

CN¥4.7b

Wanbangde Pharmaceutical Holding Group

SZSE:002082

CN¥4.3b

Chongqing Lummy Pharmaceutical

SZSE:300006

CN¥4.8b

Shanghai Fudan Forward S&T

SHSE:600624

CN¥4.9b

Price History & Performance

Summary of share price highs, lows and changes for Shanxi Zhendong PharmaceuticalLtd
Historical stock prices
Current Share PriceCN¥4.43
52 Week HighCN¥7.00
52 Week LowCN¥3.13
Beta0.40
1 Month Change-9.03%
3 Month Change14.18%
1 Year Change-32.78%
3 Year Change-44.42%
5 Year Changen/a
Change since IPO-19.31%

Recent News & Updates

Recent updates

Shareholder Returns

300158CN PharmaceuticalsCN Market
7D-7.1%-1.7%-1.0%
1Y-32.8%-4.3%10.8%

Return vs Industry: 300158 underperformed the CN Pharmaceuticals industry which returned -4.3% over the past year.

Return vs Market: 300158 underperformed the CN Market which returned 10.8% over the past year.

Price Volatility

Is 300158's price volatile compared to industry and market?
300158 volatility
300158 Average Weekly Movement9.5%
Pharmaceuticals Industry Average Movement7.4%
Market Average Movement8.8%
10% most volatile stocks in CN Market13.0%
10% least volatile stocks in CN Market5.8%

Stable Share Price: 300158 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 300158's weekly volatility (9%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19953,576Lianmin Yangwww.zdjt.com

Shanxi Zhendong Pharmaceutical Co.,Ltd, together with its subsidiaries, engages in the research and development, production, and sales of pharmaceutical drugs in China and internationally. It offers drugs for various fields, including cancer, cardiovascular, infectious disease, antibiotics, cardiocerebrovascular, antitumor, gastrointestinal, and respiratory, as well as urinary, tonic, dermatology, blood hematopoietic, digestion, urology, and heart and brain; vitamins; Chinese medicines in the form of pills, tablets, capsules, powders, and granules, as well as herbal medicines; and food and beverages for various health applications. The company engages in the pharmaceutical wholesale and logistics distribution business; tending, planting, processing, storage, and decoction of seedlings for medication applications; and offers home care and personal care products.

Shanxi Zhendong Pharmaceutical Co.,Ltd Fundamentals Summary

How do Shanxi Zhendong PharmaceuticalLtd's earnings and revenue compare to its market cap?
300158 fundamental statistics
Market capCN¥4.45b
Earnings (TTM)-CN¥2.99m
Revenue (TTM)CN¥3.11b

1.4x

P/S Ratio

-1,491x

P/E Ratio

Is 300158 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
300158 income statement (TTM)
RevenueCN¥3.11b
Cost of RevenueCN¥1.57b
Gross ProfitCN¥1.54b
Other ExpensesCN¥1.54b
Earnings-CN¥2.99m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.003
Gross Margin49.43%
Net Profit Margin-0.096%
Debt/Equity Ratio0%

How did 300158 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 20:12
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Shanxi Zhendong Pharmaceutical Co.,Ltd is covered by 5 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Wenchao JiaoPing An Securities Co. Ltd.
Yin YePing An Securities Co. Ltd.
Wen Qing WeiShenwan Hongyuan Securities